Replicel Life Sciences Inc (RP.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2017 | 12-2016 | 12-2015 | 12-2014 | 12-2013 | |
| Sales | 0 | N/A | 0 | 0 | 4,120 |
| Gross Profit | N/A | N/A | N/A | 0 | 4,120 |
| Operating Expenses | 5,992 | 4,288 | 5,047 | 5,211 | 3,737 |
| Operating Income | -5,992 | -4,288 | -5,047 | -5,211 | 383 |
| Other Income | -22 | 16 | 3 | 12 | 0 |
| Pre-tax Income | -6,014 | -4,271 | -5,044 | -5,198 | 383 |
| Income Tax | N/A | N/A | N/A | 0 | 412 |
| Net Income Continuous | -6,014 | -4,271 | -5,044 | -5,198 | -29 |
| Net Income | $-6,014 | $-4,271 | $-5,044 | $-5,198 | $-29 |
| EPS Basic Total Ops | -0.32 | -0.54 | -0.90 | -1.00 | 0.00 |
| EPS Basic Continuous Ops | -0.32 | -0.54 | -0.90 | -1.00 | 0.00 |
| EPS Diluted Total Ops | -0.32 | -0.54 | -0.90 | -1.00 | 0.00 |
| EPS Diluted Continuous Ops | -0.32 | -0.54 | -0.90 | -1.00 | 0.00 |
| EBITDA(a) | $-5,988 | $-4,282 | $-5,040 | $-5,203 | $389 |